{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:24:35Z","timestamp":1792653875934,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41433-025-03908-w","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T16:14:49Z","timestamp":1752941689000},"page":"2664-2670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Changes in accommodation and vergence parameters with topical use of 0.025% and 0.05% atropine in myopes aged between 7 and 17 years"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0421-0745","authenticated-orcid":false,"given":"Edson dos","family":"Santos-Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0142-891X","authenticated-orcid":false,"given":"Daniel Oliveira","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillan Cunha","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Carlos de","family":"Castro Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9610-5768","authenticated-orcid":false,"given":"Ricardo Noguera","family":"Louzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6759-5289","authenticated-orcid":false,"given":"Milton Ruiz","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"3908_CR1","doi-asserted-by":"publisher","unstructured":"Louzada R, Filho A, Alves M. Need for national eye health education policies in Brazil. eOftalmo. 2024; https:\/\/doi.org\/10.17545\/eOftalmo\/2024.0001.","DOI":"10.17545\/eOftalmo\/2024.0001"},{"key":"3908_CR2","doi-asserted-by":"publisher","unstructured":"Costa Neto A, Guedes J, Mora-Paez DJ, Ferreira MA, Faneli AC, Amaral DC, et al. Systematic review and meta-analysis of myopia prevalence in Brazilian school children. Revista Brasileira De Oftalmologia. 2024;83:e0056. https:\/\/doi.org\/10.37039\/1982.8551.20240056","DOI":"10.37039\/1982.8551.20240056"},{"key":"3908_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036\u201342. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006.","journal-title":"Ophthalmology"},{"key":"3908_CR4","doi-asserted-by":"publisher","first-page":"M1","DOI":"10.1167\/iovs.18-25980","volume":"60","author":"JS Wolffsohn","year":"2019","unstructured":"Wolffsohn JS, Flitcroft DI, Gifford KL, Jong M, Jones L, Klaver CCW, et al. IMI - myopia control reports overview and introduction. Invest Ophthalmol Vis Sci. 2019;60:M1\u2013M19. https:\/\/doi.org\/10.1167\/iovs.18-25980.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3908_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/OPX.0b013e3182357f79","volume":"89","author":"L Donovan","year":"2012","unstructured":"Donovan L, Sankaridurg P, Ho A, Naduvilath T, Smith EL, Holden BA. Myopia progression rates in urban children wearing single-vision spectacles. Optom Vis Sci. 2012;89:27\u201332. https:\/\/doi.org\/10.1097\/OPX.0b013e3182357f79.","journal-title":"Optom Vis Sci"},{"key":"3908_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/aos.12387","volume":"92","author":"O P\u00e4rssinen","year":"2014","unstructured":"P\u00e4rssinen O, Kauppinen M, Viljanen A. The progression of myopia from its onset at age 8-12 to adulthood and the influence of heredity and external factors on myopic progression. A 23-year follow-up study. Acta Ophthalmol. 2014;92:730\u20139. https:\/\/doi.org\/10.1111\/aos.12387.","journal-title":"Acta Ophthalmol"},{"key":"3908_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.5.2","volume":"62","author":"P Sankaridurg","year":"2021","unstructured":"Sankaridurg P, Tahhan N, Kandel H, Naduvilath T, Zou H, Frick KD, et al. IMI Impact of Myopia. Invest Ophthalmol Vis Sci. 2021;62:2. https:\/\/doi.org\/10.1167\/iovs.62.5.2.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3908_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.ophtha.2021.04.032","volume":"128","author":"MA Bullimore","year":"2021","unstructured":"Bullimore MA, Ritchey ER, Shah S, Leveziel N, Bourne RRA, Flitcroft DI. The Risks and Benefits of Myopia Control. Ophthalmology. 2021;128:1561\u201379. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.032.","journal-title":"Ophthalmology"},{"key":"3908_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1167\/iovs.61.4.49","volume":"61","author":"AEG Haarman","year":"2020","unstructured":"Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61:49. https:\/\/doi.org\/10.1167\/iovs.61.4.49.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3908_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2012.06.004","volume":"31","author":"DI Flitcroft","year":"2012","unstructured":"Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31:622\u201360. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.06.004.","journal-title":"Prog Retin Eye Res"},{"key":"3908_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29536-x","volume":"8","author":"R Dhakal","year":"2018","unstructured":"Dhakal R, Goud A, Narayanan R, Verkicharla PK. Patterns of posterior ocular complications in myopic eyes of Indian population. Sci Rep 2018;8:13700. https:\/\/doi.org\/10.1038\/s41598-018-29536-x.","journal-title":"Sci Rep"},{"key":"3908_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1475-1313.2005.00298.x","volume":"25","author":"SM Saw","year":"2005","unstructured":"Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005;25:381\u201391. https:\/\/doi.org\/10.1111\/j.1475-1313.2005.00298.x.","journal-title":"Ophthalmic Physiol Opt"},{"key":"3908_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/opo.12238","volume":"35","author":"PK Verkicharla","year":"2015","unstructured":"Verkicharla PK, Ohno-Matsui K, Saw SM. Current and predicted demographics of high myopia and an update of its associated pathological changes. Ophthalmic Physiol Opt. 2015;35:465\u201375. https:\/\/doi.org\/10.1111\/opo.12238.","journal-title":"Ophthalmic Physiol Opt"},{"key":"3908_CR14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3928\/23258160-20161004-11","volume":"47","author":"RN Louzada","year":"2016","unstructured":"Louzada RN, Ferrara D, Novais EA, Moult E, Cole E, Lane M, et al. Analysis of scleral feeder vessel in myopic choroidal neovascularization using optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retin. 2016;47:960\u20134. https:\/\/doi.org\/10.3928\/23258160-20161004-11.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"3908_CR15","doi-asserted-by":"publisher","first-page":"CD014758","DOI":"10.1002\/14651858.CD014758.pub2","volume":"2","author":"JG Lawrenson","year":"2023","unstructured":"Lawrenson JG, Shah R, Huntjens B, Downie LE, Virgili G, Dhakal R, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;2:CD014758. https:\/\/doi.org\/10.1002\/14651858.CD014758.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3908_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ophtha.2007.12.019","volume":"115","author":"KA Rose","year":"2008","unstructured":"Rose KA, Morgan IG, Ip J, Kifley A, Huynh S, Smith W, et al. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology. 2008;115:1279\u201385. https:\/\/doi.org\/10.1016\/j.ophtha.2007.12.019.","journal-title":"Ophthalmology"},{"key":"3908_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2024.100375","volume":"79","author":"DC Amaral","year":"2024","unstructured":"Amaral DC, Batista S, Dos Santos-Neto E, Manso JEF, Rodrigues MPM, Monteiro MLR, et al. Low-level red-light therapy for myopia control in children: A systematic review and meta-analysis. Clin (Sao Paulo). 2024;79:100375. https:\/\/doi.org\/10.1016\/j.clinsp.2024.100375.","journal-title":"Clin (Sao Paulo)"},{"key":"3908_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","volume":"157","author":"A Chia","year":"2014","unstructured":"Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157:451\u20137.e1. https:\/\/doi.org\/10.1016\/j.ajo.2013.09.020.","journal-title":"Am J Ophthalmol"},{"key":"3908_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","volume":"33","author":"PC Wu","year":"2019","unstructured":"Wu PC, Chuang MN, Choi J, Chen H, Wu G, Ohno-Matsui K, et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond). 2019;33:3\u201313. https:\/\/doi.org\/10.1038\/s41433-018-0139-7.","journal-title":"Eye (Lond)"},{"key":"3908_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119:347\u201354. https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.031.","journal-title":"Ophthalmology"},{"key":"3908_CR21","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s10792-021-01755-8","volume":"41","author":"L Joachimsen","year":"2021","unstructured":"Joachimsen L, Farassat N, Bleul T, B\u00f6hringer D, Lagr\u00e8ze WA, Reich M. Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study. Int Ophthalmol. 2021;41:2001\u20138. https:\/\/doi.org\/10.1007\/s10792-021-01755-8.","journal-title":"Int Ophthalmol"},{"key":"3908_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40123-019-0194-6","volume":"8","author":"L Joachimsen","year":"2019","unstructured":"Joachimsen L, B\u00f6hringer D, Gross NJ, Reich M, Stifter J, Reinhard T, et al. A pilot study on the efficacy and safety of 0.01% atropine in German schoolchildren with progressive myopia. Ophthalmol Ther. 2019;8:427\u201333. https:\/\/doi.org\/10.1007\/s40123-019-0194-6.","journal-title":"Ophthalmol Ther"},{"key":"3908_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/0301-4738.16173","volume":"53","author":"LM Abraham","year":"2005","unstructured":"Abraham LM, Kuriakose T, Sivanandam V, Venkatesan N, Thomas R, Muliyil J. Amplitude of accommodation and its relation to refractive errors. Indian J Ophthalmol. 2005;53:105\u20138. https:\/\/doi.org\/10.4103\/0301-4738.16173.","journal-title":"Indian J Ophthalmol"},{"key":"3908_CR24","doi-asserted-by":"crossref","unstructured":"Saladin J. Phorometry and stereopsis. 2006. 899-960.","DOI":"10.1016\/B978-0-7506-7524-6.50026-0"},{"key":"3908_CR25","first-page":"328","volume":"170","author":"R Dessau","year":"2008","unstructured":"Dessau R, Pipper C. \u201cR\u201d project for statistical computing. Ugeskr Laege. 2008;170:328\u201330.","journal-title":"Ugeskr Laege"},{"key":"3908_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019;126:113\u201324. https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.029","journal-title":"Ophthalmology"},{"key":"3908_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X, Tang SM, Yip BHK, Kam KW, et al. Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report. Ophthalmology. 2020;127:910\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2019.12.011.","journal-title":"Ophthalmology"},{"key":"3908_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","volume":"128","author":"FF Li","year":"2021","unstructured":"Li FF, Zhang Y, Zhang X, Yip BHK, Tang SM, Kam KW, et al. Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: low-concentration atropine for myopia progression study. Ophthalmology. 2021;128:1180\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2020.12.036.","journal-title":"Ophthalmology"},{"key":"3908_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","volume":"129","author":"JC Yam","year":"2022","unstructured":"Yam JC, Zhang XJ, Zhang Y, Wang YM, Tang SM, Li FF, et al. Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report. Ophthalmology. 2022;129:308\u201321. https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.002.","journal-title":"Ophthalmology"},{"key":"3908_CR30","doi-asserted-by":"publisher","first-page":"M106","DOI":"10.1167\/iovs.18-25958","volume":"60","author":"CF Wildsoet","year":"2019","unstructured":"Wildsoet CF, Chia A, Cho P, Guggenheim JA, Polling JR, Read S, et al. IMI - interventions myopia institute: interventions for controlling myopia onset and progression report. Invest Ophthalmol Vis Sci. 2019;60:M106\u2013M31. https:\/\/doi.org\/10.1167\/iovs.18-25958.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3908_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/opo.12614","volume":"39","author":"X Cheng","year":"2019","unstructured":"Cheng X, Xu J, Brennan N. Accommodation and its role in myopia progression and control with soft contact lenses. Ophthalmic Physiol Opt. 2019;39:162\u201371. https:\/\/doi.org\/10.1111\/opo.12614.","journal-title":"Ophthalmic Physiol Opt"},{"key":"3908_CR32","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/s41433-020-1122-7","volume":"34","author":"JR Polling","year":"2020","unstructured":"Polling JR, Tan E, Driessen S, Loudon SE, Wong HL, van der Schans A, et al. A 3-year follow-up study of atropine treatment for progressive myopia in Europeans. Eye (Lond). 2020;34:2020\u20138. https:\/\/doi.org\/10.1038\/s41433-020-1122-7.","journal-title":"Eye (Lond)"},{"key":"3908_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","volume":"40","author":"Q Tan","year":"2020","unstructured":"Tan Q, Ng AL, Choy BN, Cheng GP, Woo VC, Cho P. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial. Ophthalmic Physiol Opt. 2020;40:557\u201366. https:\/\/doi.org\/10.1111\/opo.12722.","journal-title":"Ophthalmic Physiol Opt"},{"key":"3908_CR34","doi-asserted-by":"publisher","unstructured":"Aguiar Gama I, Dutra de Oliveira AP, Sonoda RT Insufici\u00eancia De Acomoda\u00e7\u00e3o. Recima21 - Revista Cient\u00edfica Multidisciplinar - ISSN 2675-6218. 2022;3:e3112255. https:\/\/doi.org\/10.47820\/recima21.v3i11.2255.","DOI":"10.47820\/recima21.v3i11.2255"},{"key":"3908_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1167\/iovs.66.1.55","volume":"66","author":"Z Lin","year":"2025","unstructured":"Lin Z, Christaras D, Duarte-Toledo R, Yang Z, Arias A, Lan W, et al. Dynamic accommodation responses in subjects wearing myopia control spectacles modifying peripheral refraction. Invest Ophthalmol Vis Sci. 2025;66:55. https:\/\/doi.org\/10.1167\/iovs.66.1.55.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3908_CR36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41433-023-02723-5","volume":"38","author":"NS Logan","year":"2024","unstructured":"Logan NS, Bullimore MA. Optical interventions for myopia control. Eye (Lond). 2024;38:455\u201363. https:\/\/doi.org\/10.1038\/s41433-023-02723-5.","journal-title":"Eye (Lond)"},{"key":"3908_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2022.101704","volume":"46","author":"J Jiang","year":"2023","unstructured":"Jiang J, Long W, Hu Y, Zhao F, Zhao W, Zheng B, et al. Accommodation and vergence function in children using atropine combined with orthokeratology. Cont Lens Anterior Eye. 2023;46:101704. https:\/\/doi.org\/10.1016\/j.clae.2022.101704.","journal-title":"Cont Lens Anterior Eye"},{"key":"3908_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.clae.2017.01.003","volume":"40","author":"K Gifford","year":"2017","unstructured":"Gifford K, Gifford P, Hendicott PL, Schmid KL. Near binocular visual function in young adult orthokeratology versus soft contact lens wearers. Cont Lens Anterior Eye. 2017;40:184\u20139. https:\/\/doi.org\/10.1016\/j.clae.2017.01.003.","journal-title":"Cont Lens Anterior Eye"},{"key":"3908_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/OPX.0000000000002031","volume":"100","author":"RE Breliant","year":"2023","unstructured":"Breliant RE, Pang Y, Bandstra A, Kattouf V. Effect of low-dose atropine on binocular vision and accommodation in children aged 6 to 17 years. Optom Vis Sci. 2023;100:550\u20136. https:\/\/doi.org\/10.1097\/OPX.0000000000002031.","journal-title":"Optom Vis Sci"},{"key":"3908_CR40","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jamaophthalmol.2024.2295","volume":"142","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li T, Zuo X, Zhang T, Liu L, Zhou C, et al. 0.01% atropine eye drops in children with myopia and intermittent exotropia: the AMIXT randomized clinical trial. JAMA Ophthalmol. 2024;142:722\u201330. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.2295.","journal-title":"JAMA Ophthalmol"},{"key":"3908_CR41","doi-asserted-by":"publisher","first-page":"P136","DOI":"10.1016\/j.ophtha.2022.11.003","volume":"130","author":"OA Cruz","year":"2023","unstructured":"Cruz OA, Repka MX, Hercinovic A, Cotter SA, Lambert SR, Hutchinson AK, et al. Amblyopia preferred practice pattern. Ophthalmology. 2023;130:P136\u2013P78. https:\/\/doi.org\/10.1016\/j.ophtha.2022.11.003.","journal-title":"Ophthalmology"},{"key":"3908_CR42","doi-asserted-by":"publisher","unstructured":"Myles W, Dunlop C, McFadden SA. The effect of long-term low-dose atropine on refractive progression in myopic Australian school children. J Clin Med. 2021;10. https:\/\/doi.org\/10.3390\/jcm10071444.","DOI":"10.3390\/jcm10071444"},{"key":"3908_CR43","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s00417-018-4112-8","volume":"256","author":"H Kaymak","year":"2018","unstructured":"Kaymak H, Fricke A, Mauritz Y, L\u00f6winger A, Klabe K, Breyer D, et al. Short-term effects of low-concentration atropine eye drops on pupil size and accommodation in young adult subjects. Graefes Arch Clin Exp Ophthalmol. 2018;256:2211\u20137. https:\/\/doi.org\/10.1007\/s00417-018-4112-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3908_CR44","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/OPX.0000000000000037","volume":"90","author":"J Cooper","year":"2013","unstructured":"Cooper J, Eisenberg N, Schulman E, Wang FM. Maximum atropine dose without clinical signs or symptoms. Optom Vis Sci. 2013;90:1467\u201372. https:\/\/doi.org\/10.1097\/OPX.0000000000000037.","journal-title":"Optom Vis Sci"},{"key":"3908_CR45","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.ophtha.2017.05.032","volume":"124","author":"SL Pineles","year":"2017","unstructured":"Pineles SL, Kraker RT, VanderVeen DK, Hutchinson AK, Galvin JA, Wilson LB, et al. Atropine for the prevention of myopia progression in children: a report by the American academy of ophthalmology. Ophthalmology. 2017;124:1857\u201366. https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.032.","journal-title":"Ophthalmology"},{"key":"3908_CR46","doi-asserted-by":"publisher","unstructured":"Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113. https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.062.","DOI":"10.1016\/j.ophtha.2006.05.062"},{"key":"3908_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/APO.0000000000000414","volume":"10","author":"HDM Tran","year":"2021","unstructured":"Tran HDM, Sankaridurg P, Naduvilath T, Ha TTX, Tran TD, Jong M, et al. A meta-analysis assessing change in pupillary diameter, accommodative amplitude, and efficacy of atropine for myopia control. Asia Pac J Ophthalmol (Philos). 2021;10:450\u201360. https:\/\/doi.org\/10.1097\/APO.0000000000000414.","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"3908_CR48","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.18240\/ijo.2018.10.13","volume":"11","author":"JS Moon","year":"2018","unstructured":"Moon JS, Shin SY. The diluted atropine for inhibition of myopia progression in Korean children. Int J Ophthalmol. 2018;11:1657\u201362. https:\/\/doi.org\/10.18240\/ijo.2018.10.13.","journal-title":"Int J Ophthalmol"},{"key":"3908_CR49","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1136\/bjophthalmol-2015-307861","volume":"100","author":"J Loughman","year":"2016","unstructured":"Loughman J, Flitcroft DI. The acceptability and visual impact of 0.01% atropine in a Caucasian population. Br J Ophthalmol. 2016;100:1525\u20139. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307861.","journal-title":"Br J Ophthalmol"},{"key":"3908_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/jop.1994.10.217","volume":"10","author":"MM Salazar-Bookaman","year":"1994","unstructured":"Salazar-Bookaman MM, Wainer I, Patil PN. Relevance of drug-melanin interactions to ocular pharmacology and toxicology. J Ocul Pharm. 1994;10:217\u201339. https:\/\/doi.org\/10.1089\/jop.1994.10.217.","journal-title":"J Ocul Pharm"},{"key":"3908_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88719-1","volume":"11","author":"A Fu","year":"2021","unstructured":"Fu A, Stapleton F, Wei L, Wang W, Zhao B, Watt K, et al. Risk factors for rapid axial length elongation with low concentration atropine for myopia control. Sci Rep 2021;11:11729. https:\/\/doi.org\/10.1038\/s41598-021-88719-1.","journal-title":"Sci Rep"},{"key":"3908_CR52","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00417-022-05863-8","volume":"261","author":"WL Bai","year":"2023","unstructured":"Bai WL, Gan JH, Wei S, Li SM, An WZ, Liang XT, et al. Effect of low-dose atropine eyedrops on pupil metrics: results after half a year of treatment and cessation. Graefes Arch Clin Exp Ophthalmol. 2023;261:1177\u201386. https:\/\/doi.org\/10.1007\/s00417-022-05863-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3908_CR53","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.4103\/ijo.IJO_2956_20","volume":"69","author":"C Padavettan","year":"2021","unstructured":"Padavettan C, Nishanth S, Vidhyalakshmi S, Madhivanan N. Changes in vergence and accommodation parameters after smartphone use in healthy adults. Indian J Ophthalmol. 2021;69:1487\u201390. https:\/\/doi.org\/10.4103\/ijo.IJO_2956_20.","journal-title":"Indian J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03908-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03908-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03908-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:21:31Z","timestamp":1758190891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03908-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3908"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03908-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors report no relationships that could be construed as a conflict of interest. They also take responsibility for the reliability and freedom from bias of the data presented and their discussed interpretation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}